Could it be time to talk in the long-running saga of Sanofi-Aventis SA's (SASY.PA) $18.5 billion bid for Genzyme Corp (GENZ.O)? There is certainly the opportunity. The two chief executives at the centre of a takeover battle that has transfixed the drugs industry for the last six months will bump into each other twice in January at high-profile events on either side of the world. On Jan. 11, Genzyme CEO Henri Termeer and Sanofi's Chris Viehbacher are set to give back-to-back presentations at the annual JPMorgan Healthcare Conference in San Francisco.
Source
